Stephen Hoge serves as Executive at Moderna, Inc., where they oversee executive responsibilities. Since joining the company, Stephen Hoge has executed 703 insider transactions totaling $295.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2025 involved selling 316 shares valued at $8.2K.
Stephen Hoge currently holds 1,454,905 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Hoge has been a net seller of MRNA stock. They have purchased $0 and sold $295.8M worth of shares.
Stephen Hoge's most recent insider trade was on Dec 1, 2025, when they sold 316 shares at $25.98 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 28, 2025 | MRNA | $0 | Option Exercise | 610 | $N/A | Discretionary |
| Nov 28, 2025 | MRNA | $7.4K | Payment | 295 | $25.01 | Discretionary |
| Nov 26, 2025 | MRNA | $0 | Option Exercise | 1,437 | $N/A | Discretionary |
| Nov 26, 2025 | MRNA | $17.2K | Payment | 695 | $24.75 | Discretionary |
| Aug 29, 2025 | MRNA | $7.7K | Payment | 315 | $24.47 | Discretionary |
| Aug 29, 2025 | MRNA | $0 | Option Exercise | 651 | $N/A | Discretionary |
| Aug 28, 2025 | MRNA | $0 | Option Exercise | 611 | $N/A | Discretionary |
| Aug 28, 2025 | MRNA | $7.4K | Payment | 296 | $25.10 | Discretionary |
| Aug 27, 2025 | MRNA | $17.2K | Payment | 695 | $24.73 | Discretionary |
| Aug 27, 2025 | MRNA | $0 | Option Exercise | 1,437 | $N/A | Discretionary |
| Sep 3, 2024 | MRNA | $24.5K | Sale | 318 | $76.99 | Planned |
| Aug 30, 2024 | MRNA | $0 | Option Exercise | 652 | $N/A | Planned |
| Aug 29, 2024 | MRNA | $23.4K | Sale | 300 | $78.03 | Planned |
| Aug 28, 2024 | MRNA | $0 | Option Exercise | 611 | $N/A | Planned |
| Aug 12, 2024 | MRNA | $21.4K | Sale | 254 | $84.10 | Planned |
| Aug 9, 2024 | MRNA | $0 | Option Exercise | 522 | $N/A | Planned |
| Jul 15, 2024 | MRNA | $1.8M | Sale | 15,000 | $121.12 | Planned |
| Jun 17, 2024 | MRNA | $2.1M | Sale | 15,000 | $138.16 | Planned |
| Jun 3, 2024 | MRNA | $47.7K | Sale | 339 | $140.72 | Planned |
| May 31, 2024 | MRNA | $0 | Option Exercise | 651 | $N/A | Planned |
| May 29, 2024 | MRNA | $49.3K | Sale | 341 | $144.50 | Planned |
| May 28, 2024 | MRNA | $0 | Option Exercise | 610 | $N/A | Planned |
| May 15, 2024 | MRNA | $1.9M | Sale | 15,000 | $127.49 | Planned |
| May 10, 2024 | MRNA | $30.8K | Sale | 255 | $120.96 | Planned |
| May 9, 2024 | MRNA | $0 | Option Exercise | 522 | $N/A | Planned |
| Apr 15, 2024 | MRNA | $1.6M | Sale | 15,000 | $105.02 | Planned |
| Mar 15, 2024 | MRNA | $1.5M | Sale | 15,000 | $103.17 | Planned |
| Mar 4, 2024 | MRNA | $29.2K | Sale | 309 | $94.34 | Planned |